Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6807)
All Articles published online
|
Publishing Process of This Article
|
Jan 7, 2015 (publication date) through Apr 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cevik D, Yildiz G, Ozturk M. Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations. World J Gastroenterol 2015; 21(1): 311-317 [PMID: 25574106 DOI: 10.3748/wjg.v21.i1.311] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i1/311.htm |
| Number | Citing Articles |
| 1 |
Robert J.A. Bell, H. Tomas Rube, Ana Xavier-Magalhães, Bruno M. Costa, Andrew Mancini, Jun S. Song, Joseph F. Costello. Understanding TERT Promoter Mutations: A Common Path to Immortality. Molecular Cancer Research 2016; 14(4): 315 doi: 10.1158/1541-7786.MCR-16-0003
|
| 2 |
Paola Valeria Marchese, Veronica Mollica, Elisa Tassinari, Dario De Biase, Francesca Giunchi, Andrea Marchetti, Matteo Rosellini, Michelangelo Fiorentino, Francesco Massari. Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers. Expert Review of Molecular Diagnostics 2022; 22(11): 997 doi: 10.1080/14737159.2022.2154148
|
| 3 |
Masayuki Akita, Tetsuo Ajiki, Takumi Fukumoto, Tomoo Itoh, Yoh Zen. Keratin 19‐expressing hepatocellular carcinoma and small‐duct type intrahepatic cholangiocarcinoma show a similar postoperative clinical course but have distinct genetic features. Histopathology 2019; 75(3): 385 doi: 10.1111/his.13884
|
| 4 |
Ngo Tat Trung, Nghiem Xuan Hoan, Pham Quang Trung, Mai Thanh Binh, Hoang Van Tong, Nguyen Linh Toan, Mai Hong Bang, Le Huu Song. Clinical significance of combined circulating TERT promoter mutations and miR-122 expression for screening HBV-related hepatocellular carcinoma. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65213-8
|
| 5 |
Jean-Charles Nault, Jessica Zucman-Rossi. TERT promoter mutations in primary liver tumors. Clinics and Research in Hepatology and Gastroenterology 2016; 40(1): 9 doi: 10.1016/j.clinre.2015.07.006
|
| 6 |
Sonja Helbig, Leesa Wockner, Annick Bouendeu, Ursula Hille-Betz, Karen McCue, Juliet D. French, Stacey L. Edwards, Hilda A. Pickett, Roger R. Reddel, Georgia Chenevix-Trench, Thilo Dörk, Jonathan Beesley. Functional dissection of breast cancer risk-associated TERT promoter variants. Oncotarget 2017; 8(40): 67203 doi: 10.18632/oncotarget.18226
|
| 7 |
Zhengqing Bao, Shiming He, Dong Fang, Bao Guan, Lei Zhang, Gengyan Xiong, Xinyu Yang, Qun He, Xuesong Li, Liqun Zhou. Prognostic Significance of Murine Double Minute 2 Expression in Tumor Cells in Upper Tract Urothelial Carcinoma: An Analysis of 341 Cases in a Large Chinese Center. Genetic Testing and Molecular Biomarkers 2019; 23(11): 797 doi: 10.1089/gtmb.2019.0126
|
| 8 |
Barbara Heidenreich, Rajiv Kumar. TERT promoter mutations in telomere biology. Mutation Research/Reviews in Mutation Research 2017; 771: 15 doi: 10.1016/j.mrrev.2016.11.002
|
| 9 |
Abdul K. Siraj, Rong Bu, Kaleem Iqbal, Sandeep Kumar Parvathareddy, Nabil Siraj, Sarah Siraj, Mark Ranier F. Diaz, Dionne Rae Rala, Allianah D. Benito, Maria Angelita Sabido, Maha Al-Rasheed, Khadija A.S. Al-Obaisi, Wael Al-Haqawi, Ingrid G. Victoria, Wafaa Al Balawy, Malak Abedalthagafi, Salma Majid Wakil, Dahish Ajarim, Shamayel Mohammed, Turki Alhussain, Asma Tulbah, Ismail A. Al-Badawi, Fouad Al-Dayel, Khawla S. Al-Kuraya. Telomerase reverse transcriptase promoter mutations in cancers derived from multiple organ sites among middle eastern population. Genomics 2020; 112(2): 1746 doi: 10.1016/j.ygeno.2019.09.017
|
| 10 |
Hengning Ke, Rui Yuan, Huan Liu, Mingqi Luo, Hui Hu, Ejuan Zhang, Ke Zhuang, Yong Yang, Rongrong Yang. Serum protein biomarkers for HCC risk prediction in HIV/HBV co-infected people: a clinical proteomic study using mass spectrometry. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1282469
|
| 11 |
Sarah E. Woodfield, Yan Shi, Roma H. Patel, Jingling Jin, Angela Major, Stephen F. Sarabia, Zbigniew Starosolski, Barry Zorman, Siddharth S. Gupta, Zhenghu Chen, Aryana M. Ibarra, Karl-Dimiter Bissig, Ketan B. Ghaghada, Pavel Sumazin, Dolores López-Terrada, Sanjeev A. Vasudevan. A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-17665-8
|
| 12 |
Benedetta Donati, Luca Valenti. Telomeres, NAFLD and Chronic Liver Disease. International Journal of Molecular Sciences 2016; 17(3): 383 doi: 10.3390/ijms17030383
|
| 13 |
Fotini Papachristou, Nikolia Anninou, Georgios Koukoulis, Stefanos Paraskakis, Eleni Sertaridou, Christos Tsalikidis, Michael Pitiakoudis, Constantinos Simopoulos, Alexandra Tsaroucha. Differential effects of cisplatin combined with the flavonoid apigenin on HepG2, Hep3B, and Huh7 liver cancer cell lines. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2021; 866: 503352 doi: 10.1016/j.mrgentox.2021.503352
|
| 14 |
Lena in der Stroth, Umesh Tharehalli, Cagatay Günes, André Lechel. Telomeres and Telomerase in the Development of Liver Cancer. Cancers 2020; 12(8): 2048 doi: 10.3390/cancers12082048
|
| 15 |
Srishti Kotiyal, Kimberley Jane Evason. Exploring the Interplay of Telomerase Reverse Transcriptase and β-Catenin in Hepatocellular Carcinoma. Cancers 2021; 13(16): 4202 doi: 10.3390/cancers13164202
|
| 16 |
Tsung-Jang Yeh, Chi-Wen Luo, Jeng-Shiun Du, Chien-Tzu Huang, Min-Hung Wang, Tzer-Ming Chuang, Yuh-Ching Gau, Shih-Feng Cho, Yi-Chang Liu, Hui-Hua Hsiao, Li-Tzong Chen, Mei-Ren Pan, Hui-Ching Wang, Sin-Hua Moi. Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer. Biomedicines 2023; 11(3): 691 doi: 10.3390/biomedicines11030691
|
| 17 |
Muhammad Ramlee, Jing Wang, Wei Toh, Shang Li. Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene. Genes 2016; 7(8): 50 doi: 10.3390/genes7080050
|
| 18 |
Andreas Schmidt, Angela Armento, Ovidio Bussolati, Martina Chiu, Verena Ellerkamp, Marcus O. Scharpf, Philip Sander, Evi Schmid, Steven W. Warmann, Jörg Fuchs. Hepatoblastoma: glutamine depletion hinders cell viability in the embryonal subtype but high GLUL expression is associated with better overall survival. Journal of Cancer Research and Clinical Oncology 2021; 147(11): 3169 doi: 10.1007/s00432-021-03713-4
|
| 19 |
Tiago Bordeira Gaspar, Ana Sá, José Manuel Lopes, Manuel Sobrinho-Simões, Paula Soares, João Vinagre. Telomere Maintenance Mechanisms in Cancer. Genes 2018; 9(5): 241 doi: 10.3390/genes9050241
|
| 20 |
Simona Ruta, Laura Grecu, Diana Iacob, Costin Cernescu, Camelia Sultana. HIV-HBV Coinfection—Current Challenges for Virologic Monitoring. Biomedicines 2023; 11(5): 1306 doi: 10.3390/biomedicines11051306
|
| 21 |
Viktoriia A. Arzumanian, Olga I. Kiseleva, Ekaterina V. Poverennaya. The Curious Case of the HepG2 Cell Line: 40 Years of Expertise. International Journal of Molecular Sciences 2021; 22(23): 13135 doi: 10.3390/ijms222313135
|
| 22 |
François Hafezi, Danielle Perez Bercoff. The Solo Play of TERT Promoter Mutations. Cells 2020; 9(3): 749 doi: 10.3390/cells9030749
|
| 23 |
Xunjun Yang, Xiuchan Guo, Yao Chen, Guorong Chen, Yin Ma, Kate Huang, Yuning Zhang, Qiongya Zhao, Cheryl A. Winkler, Ping An, Jianxin Lyu. Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma. Oncotarget 2016; 7(19): 27838 doi: 10.18632/oncotarget.8539
|
| 24 |
Peiliang Geng, Xiaoxin Zhao, Juanjuan Ou, Jianjun Li, Rina Sa, Houjie Liang.
TERT Genetic Mutations as Prognostic Marker in Glioma. Molecular Neurobiology 2017; 54(5): 3665 doi: 10.1007/s12035-016-9930-2
|
| 25 |
Fan‐kai Xiao, Sen Guo, Fan Yang, Luo‐sha Zhao, Li‐dong Wang. MDM2 and its functional polymorphism SNP309 contribute to the development of esophageal carcinoma. The Journal of Gene Medicine 2019; 21(5) doi: 10.1002/jgm.3086
|
| 26 |
Tiantian Liu, Xiaotian Yuan, Dawei Xu. Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications. Genes 2016; 7(7): 38 doi: 10.3390/genes7070038
|
| 27 |
De‑Yong Gao, Yun Ling, Xiao‑Li Lou, Ying‑Ying Wang, Liang‑Ming Liu. GTSF1 gene may serve as a novel potential diagnostic biomarker for liver cancer. Oncology Letters 2017; doi: 10.3892/ol.2017.7695
|
| 28 |
Hani Alotaibi, Nese Atabey, Kasım Diril, Esra Erdal, Mehmet Ozturk. Hepatocellular Carcinoma. 2016; : 43 doi: 10.1007/978-3-319-34214-6_3
|
| 29 |
Francesca Pezzuto, Luigi Buonaguro, Franco M. Buonaguro, Maria Lina Tornesello. Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma. Infectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0138-5
|
| 30 |
Aurélie Beaufrère, Sarah Paisley, Ibrahima Ba, Samira Laouirem, Victoria Priori, Hélène Cazier, Loëtitia Favre, François Cauchy, Mickael Lesurtel, Julien Calderaro, Caroline Kannengiesser, Valérie Paradis. Differential diagnosis of small hepatocellular nodules in cirrhosis: surrogate histological criteria of TERT promoter mutations. Histopathology 2024; 84(3): 473 doi: 10.1111/his.15086
|
| 31 |
Jing-Jing Han, Yu Chen, Yu-Chen Nan, Yong-Lin Yang. Extremely high titer of hepatitis B surface antigen antibodies in a primary hepatocellular carcinoma patient: A case report. World Journal of Clinical Cases 2021; 9(28): 8492-8497 doi: 10.12998/wjcc.v9.i28.8492
Abstract(375) |
Core Tip(357) |
Full Article(HTML)(1623)
|
Full Article (PDF)-1812K(205)
|
Full Article (Word)-481K(203)
|
Audio-195K(5)
|
Peer-Review Report-196K(73)
|
Answering Reviewers-211K(75)
|
Times Cited (0)
|
Total Visits (5891)
|
Open
|
| 32 |
Mohammad A. Jafri, Shakeel A. Ansari, Mohammed H. Alqahtani, Jerry W. Shay. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. Genome Medicine 2016; 8(1) doi: 10.1186/s13073-016-0324-x
|
| 33 |
Siarhei A. Dabravolski, Evgeny E. Bezsonov, Alexander N. Orekhov. The role of mitochondria dysfunction and hepatic senescence in NAFLD development and progression. Biomedicine & Pharmacotherapy 2021; 142: 112041 doi: 10.1016/j.biopha.2021.112041
|
| 34 |
Mehmet Ozturk, Tugce Batur, Umut Ekin, Aybike Erdogan, Evin İscan, Umur Keles, Ozden Oz, Cigdem Ozen. Molecular Pathogenesis of Liver Cancer. Journal of Gastrointestinal Cancer 2017; 48(3): 222 doi: 10.1007/s12029-017-9957-2
|
| 35 |
Jean-Charles Nault, Massih Ningarhari, Sandra Rebouissou, Jessica Zucman-Rossi. The role of telomeres and telomerase in cirrhosis and liver cancer. Nature Reviews Gastroenterology & Hepatology 2019; 16(9): 544 doi: 10.1038/s41575-019-0165-3
|
| 36 |
Gokhan Yildiz. Integrated multi‑omics data analysis identifying novel drug sensitivity‑associated molecular targets of hepatocellular carcinoma cells. Oncology Letters 2018; doi: 10.3892/ol.2018.8634
|
| 37 |
Zhenyang Luo. Proceedings of the 2023 2nd International Conference on Social Sciences and Humanities and Arts (SSHA 2023). Advances in Social Science, Education and Humanities Research 2023; 752: 67 doi: 10.2991/978-2-38476-062-6_10
|
| 38 |
Hye Won Lee, Tae In Park, Se Young Jang, Soo Young Park, Won-Jin Park, Soo-Jung Jung, Jae-Ho Lee. Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma. Medicine 2017; 96(5): e5766 doi: 10.1097/MD.0000000000005766
|
| 39 |
Ran Chen, Moubin Lin, Daming Gao. Major genomic mutations driving hepatocellular carcinoma. Genome Instability & Disease 2023; 4(4): 239 doi: 10.1007/s42764-023-00103-7
|
| 40 |
G.D. Khedkar, B. Prakash, C.D. Khedkar, B.A. Chopade. Encyclopedia of Food and Health. 2016; : 84 doi: 10.1016/B978-0-12-384947-2.00487-6
|
| 41 |
Ming Wang, Dong Xi, Qin Ning. Virus-induced hepatocellular carcinoma with special emphasis on HBV. Hepatology International 2017; 11(2): 171 doi: 10.1007/s12072-016-9779-5
|
| 42 |
Anju Jose, Maria Grazia Bavetta, Erika Martinelli, Fabrizio Bronte, Emilio Francesco Giunta, Kanjoormana Aryan Manu, Alessandro Granito. Hepatocellular Carcinoma: Current Therapeutic Algorithm for Localized and Advanced Disease. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/3817724
|
| 43 |
Francesca Pezzuto, Francesco Izzo, Luigi Buonaguro, Clorinda Annunziata, Fabiana Tatangelo, Gerardo Botti, Franco M. Buonaguro, Maria Lina Tornesello. Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma. Oncotarget 2016; 7(34): 54253 doi: 10.18632/oncotarget.9801
|
| 44 |
François Hafezi, Lisa Jaxel, Morgane Lemaire, Jonathan D. Turner, Danielle Perez-Bercoff. TERT Promoter Mutations Increase Sense and Antisense Transcription from the TERT Promoter. Biomedicines 2021; 9(12): 1773 doi: 10.3390/biomedicines9121773
|
| 45 |
Sanandan Malhotra, Mallory Freeberg, Shelby Winans, James Taylor, Karen Beemon. A Novel Long Non-Coding RNA in the hTERT Promoter Region Regulates hTERT Expression. Non-Coding RNA 2017; 4(1): 1 doi: 10.3390/ncrna4010001
|
| 46 |
So Young Kang, Deok Geun Kim, Hyunjin Kim, Yoon Ah Cho, Sang Yun Ha, Ghee Young Kwon, Kee-Taek Jang, Kyoung-Mee Kim. Direct comparison of the next-generation sequencing and iTERT PCR methods for the diagnosis of TERT hotspot mutations in advanced solid cancers. BMC Medical Genomics 2022; 15(1) doi: 10.1186/s12920-022-01175-2
|
| 47 |
Radhika Tippani, Sirisha Kalam, Srinivas Podeti, Mahendar Porika. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 181 doi: 10.1016/B978-0-323-98806-3.00019-2
|
| 48 |
Maria Tagliamonte, Annacarmen Petrizzo, Maria Napolitano, Antonio Luciano, Claudio Arra, Piera Maiolino, Francesco Izzo, Maria Lina Tornesello, Luigi Aurisicchio, Gennaro Ciliberto, Franco M. Buonaguro, Luigi Buonaguro. Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model. Cancer Immunology, Immunotherapy 2015; 64(10): 1305 doi: 10.1007/s00262-015-1698-0
|
| 49 |
Claudia Campani, Jessica Zucman-Rossi, Jean-Charles Nault. Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNA. Cancers 2023; 15(3): 817 doi: 10.3390/cancers15030817
|
| 50 |
Zhao-Shan Niu, Xiao-Jun Niu, Wen-Hong Wang. Genetic alterations in hepatocellular carcinoma: An update. World Journal of Gastroenterology 2016; 22(41): 9069-9095 doi: 10.3748/wjg.v22.i41.9069
|